Discovery of 1,1′-Biphenyl-4-sulfonamides as a New Class of Potent and Selective Carbonic Anhydrase XIV Inhibitors

被引:35
|
作者
La Regina, Giuseppe [1 ]
Coluccia, Antonio [1 ]
Famiglini, Valeria [1 ]
Pelliccia, Sveva [1 ]
Monti, Ludovica [1 ]
Vullo, Daniela [2 ]
Nuto, Elisa [3 ]
Aterio, Vincenzo [4 ]
De Simone, Giuseppina [4 ]
Monti, Simona Maria [4 ]
Pan, Peiwen [5 ,6 ]
Parkkila, Seppo [5 ,6 ]
Supuran, Claudiu T. [2 ]
Rossello, Armando [3 ]
Silvestri, Romano [1 ]
机构
[1] Univ Roma La Sapienza, Ist Pasteur Italia, Fdn Cenci Bolognetti, Dipartimento Chim & Tecnol Farmaco, Piazzale Aldo Moro 5, I-00185 Rome, Italy
[2] Univ Florence, Dipartimento Neurofarba, Sez Sci Farmaceut & Nutraceut, I-50019 Florence, Italy
[3] Univ Pisa, Dipartimento Farm, I-56126 Pisa, Italy
[4] CNR, Ist Biostrutture & Bioimmmagini, I-80134 Naples, Italy
[5] Univ Tampere, Sch Med, Tampere 33014, Finland
[6] Tampere Univ Hosp, Tampere 33014, Finland
关键词
DRUG DESIGN; CRYSTALLOGRAPHY; TARGETS; IX;
D O I
10.1021/acs.jmedchem.5b01144
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
New 1,1'-biphenylsulfonamides were synthesized and evaluated as inhibitors of the ubiquitous human carbonic anhydrase isoforms I, II, IX, XII, and XIV using acetazolamide (AAZ) as reference compound. The sulfonamides 1-21 inhibited all the isoforms, with K-i values in the nanomolar range of concentration, and were superior to AAZ against all of them. X-ray crystallography and molecular modeling studies on the adducts that compound 20, the most potent hCA XIV inhibitor of the series (K-i, = 0.26 nM), formed with the five hCAs, provided insight into the molecular determinants responsible for the high affinity of this molecule toward the target enzymes. The results pave the way to the development of 1.1'-biphenylsulfonamides as a new class of highy potent hCA XIV inhibitors.
引用
收藏
页码:8564 / 8572
页数:9
相关论文
共 50 条
  • [31] Discovery of potent carbonic anhydrase, acetylcholinesterase, and butyrylcholinesterase enzymes inhibitors: The new amides and thiazolidine-4-ones synthesized on an acetophenone base
    Taslimi, Parham
    Osmanova, Sabiya
    Gulcin, Ilhami
    Sardarova, Sabira
    Farzaliyev, Vagif
    Sujayev, Afsun
    Kaya, Ruya
    Koc, Fatma
    Beydemir, Sukru
    Alwasel, Saleh H.
    Kufrevioglu, Omer Irfan
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2017, 31 (09)
  • [32] Discovery of New Selenoureido Analogues of 4-(4-Fluorophenylureido)benzenesulfonamide as Carbonic Anhydrase Inhibitors
    Angeli, Andrea
    Tanini, Damiano
    Peat, Thomas S.
    Mannelli, Lorenzo Di Cesare
    Bartolucci, Gianluca
    Capperucci, Antonella
    Ghelardini, Carla
    Supuran, Claudiu T.
    Carta, Fabrizio
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (09): : 963 - 968
  • [33] Discovery of benzoylisoindolines as a novel class of potent, selective and orally active GlyT1 inhibitors
    Pinard, Emmanuel
    Alberati, Daniela
    Bender, Markus
    Borroni, Edilio
    Brom, Virginie
    Burner, Serge
    Fischer, Holger
    Hainzl, Dominik
    Halm, Remy
    Hauser, Nicole
    Jolidon, Synese
    Lengyel, Judith
    Marty, Hans-Peter
    Meyer, Thierry
    Moreau, Jean-Luc
    Mory, Roland
    Narquizian, Robert
    Norcross, Roger D.
    Schmid, Philipp
    Wermuth, Roger
    Zimmerli, Daniel
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (23) : 6960 - 6965
  • [34] Discovery of amidines as a novel class of potent and selective 11β- hydroxysteroid dehydrogenase Type 1 inhibitors
    Patel, Meena V.
    Peddi, Sridhar
    Rohde, Jeffrey J.
    Lange, Udo E. W.
    Hornberger, Wilfried
    Backfisch, Gisela
    Shebly, Mohamad
    Jacobson, Peer
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [35] Discovery of 1,6-naphthyridines as a novel class of potent and selective human cytomegalovirus inhibitors
    Chan, L
    Jin, H
    Stefanac, T
    Lavallée, JF
    Falardeau, G
    Wang, W
    Bédard, J
    May, S
    Yuen, L
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (16) : 3023 - 3025
  • [36] Superacid synthesis of halogen containing N-substituted-4-aminobenzene sulfonamides: New selective tumor-associated carbonic anhydrase inhibitors
    Compain, Guillaume
    Martin-Mingot, Agnes
    Maresca, Alfonso
    Thibaudeau, Sebastien
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (06) : 1555 - 1563
  • [37] Piperazine sulfonamides as potent, selective, and orally available 1 1b-HSD1 inhibitors
    Xiang, Jason S.
    Wan, Zhao-Kui
    Ipek, Manus
    Chenail, Eva
    Li, Huan-Qiu
    Jin, Guixian
    Aulabaugh, Ann
    Bard, Joel
    McKew, John C.
    Tam, Steve
    Mansour, Tarek
    Xu, Xin
    Suri, Vipin
    Xing, Yuzhe
    Goodman, Jessie
    Li, Xiangping
    Hahm, Seung
    Tobin, James
    Saiah, Eddine
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [38] MEDI 398-Discovery and optimization of a potent and selective new class of PDE4 inhibitors
    Skoumbourdis, Amanda P.
    LeClair, Christopher A.
    Huang, Ruili
    Southall, Noel
    Leister, William
    Inglese, James
    Austin, Christopher P.
    Xia, Menghang
    Thomas, Craig J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [39] Discovery of new class of potent and selective COX-2 inhibitors.
    Wang, Z
    Black, WC
    Brideau, C
    Chan, C
    Charleson, S
    Cromlish, W
    Denis, D
    Ethier, D
    Evans, J
    Falgueyret, JP
    FordHutchinson, A
    Gauthier, JY
    Gordon, R
    Greig, G
    Gresser, M
    Grimm, E
    Guay, J
    Leblanc, Y
    Leger, S
    Kargman, S
    Mancini, J
    ONeill, G
    Ouellet, M
    Percival, D
    Prasit, P
    Riendeau, D
    Rodger, I
    Skorey, K
    Tagari, P
    Therien, M
    Wong, E
    Young, RN
    Xu, L
    Zamboni, R
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 16 - MEDI
  • [40] Carbonic anhydrase inhibitors: Synthesis of water soluble sulfonamides incorporating a 4-sulfamoylphenylmethylthiourea scaffold, with potent intraocular pressure lowering properties
    Casini, A
    Scozzafava, A
    Mincione, F
    Menabuoni, L
    Supuran, CT
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2002, 17 (05) : 333 - 343